期刊文献+

依托泊苷提高复制缺陷型腺病毒介导外源基因在肿瘤细胞中的表达水平 被引量:4

Etoposide enhances transgene expression mediated by recombinant replication-defective adenovirus in tumor cell lines
下载PDF
导出
摘要 目的:研究化疗药物依托泊苷对腺病毒载体介导的外源基因在肿瘤细胞内表达水平的影响。方法:携带外源基因增强型绿色荧光蛋白(EGFP)的复制缺陷型腺病毒Ad5-CMV-EGFP(MOI为1或10)单独或联合终质量浓度为0.2、2、20、40、80、100和200μg/ml的依托泊苷感染体外培养的肿瘤细胞NCI-H446(人非小细胞肺癌细胞株)、A549(人肺腺癌细胞株)、SMMC-7721(人肝癌细胞株)、SGC7901(人胃癌细胞株)、SKBR-3(人乳腺癌细胞株)和BTT(小鼠膀胱移行上皮癌细胞株)后不同时间,流式细胞仪分析肿瘤细胞EGFP阳性率和平均荧光强度,Western blotting检测EGFP蛋白表达,RT—PCR和实时荧光定量PCR检测肿瘤细胞内EGFP的mRNA表达量和DNA拷贝数。结果:不同剂量的依托泊苷可不同程度地提高Ad5-CMV-EGFP在7种肿瘤细胞内的表达水平,但对EGFP阳性率无明显提高。10 MOI的Ad5-CMV-EGFP联合40μg/ml依托泊苷分别感染肿瘤细胞NCI-H446、NCI-H460、A549、SMMC-7721、SGC7901、SKBR-3和BTT 24h后,细胞内EGFP的荧光强度分别是单独感染的3.3、3.5、3.1、6.2、7.0、5.4和3.4倍。Ad5-CMV-EGFP联合应用依托泊苷后肿瘤细胞内EGFP蛋白表达增加2~5倍,EGFP mRNA表达量提高,但DNA拷贝数未见明显改变。结论:依托泊苷可提高腺病毒载体介导的外源基因在肿瘤细胞内的表达水平,该作用可能是在转录水平上发挥作用的。 Objective: To investigate the effects of chemotherapeutic agent Etoposide on transgene expression mediated by recombinant replication-defective adenovirus in tumor cell lines. Methods : Cultured tumor cells, including NCI-H446, NCI-H460, A549, SMMC-7721, SGC7901, SKBR-3, and BTT were infected by Ad-CMV-EGFP alone (MOI being 1 and 10) or in combination with Etoposide at different final concentrations (0.2, 2, 20, 40, 80, 100 and 200 μg/ml). GFP positive cell rates and the mean intensities of GFP fluorescence in tumor cells were detected by Fluorescence Activated Cell Sorting (FACS) after cultured with different strategies. EGFP protein expression in tumor cells was analyzed by Western blotting. Quantitative analysis of mRNA and DNA copies of EGFP in tumor cells were performed by RT-PCR and real-time PCR. Results: FACS results indicated that Etoposide efficiently enhanced the mean intensities of EGFP fluorescence to different degrees in all 7 cell lines but had no evident effects on the EGFP positive rate. Twenty-four hours after cultured at the presence of 10 MOI Ad5-CMV-EGFP and 40 μg/ml Etoposide, the mean intensities of EGFP fluorescence in NCI-H446, NCI-H460, A549, SMMC-7721, SGC7901, SKBR-3, and BTT cells were respectively 3.3, 3.5, 3.1, 6.2, 7.0, 5.4, and 3.4 folds that cultured with 10 MOI Ad5-CMV-EGFP alone. Western blotting showed that EGFP protein expression in cells co-cultured with Ad5-CMV-EGFP and Etoposide was 2-5 times that cultured with 10 MOI Ad5-CMV-EGFP alone. EGFP mRNA expression had a similar tendency as EGFP protein, but the copies of EGFP DNA had no evident changes. Conclusion: Etoposide can enhance transgene expression mediated by recombination replication-defective adenovirus in several tumor cell lines, which may play a role at the transcriptional level.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 2007年第1期14-20,共7页 Chinese Journal of Cancer Biotherapy
基金 国家自然科学基金杰出青年资助项目(No.30325043) 国家重点基础研究发展计划(973)项目(No.2004CB518804) 上海市卫生局医学领军人才基金资助项目 上海市科学技术委员会"登山计划项目"(No.064119539)
关键词 复制缺陷型腺病毒 依托泊苷 肿瘤 基因表达 replication-defective adenovirus etoposide tumor gene expression
  • 相关文献

参考文献19

  • 1Ganjavi H,Gee M,Narendran A,et al.Adenovirus-mediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines:Sensitization to cisplatin and doxorubicin[J].Cancer Gene Ther,2005,12(4):397-406.
  • 2Raki M,Kanerva A,Ristimaki A,et al.Combination of gemcitabine and Ad5/3-D24,a tropism modified conditionally replicating adenovirus for the treatment of ovarian cancer[J].Gene Ther,2005,12(15),1198-1205.
  • 3Yamaguchi Y,Shiraki K,Fuke H,et al.Adenovirus-mediated transfection of caspase-8 sensitizes hepatocellular carcinoma to TRAIL-and chemotherapeutic agent-induced cell death[J].Biochim Biophys Acta,2006,1763(8):844-853.
  • 4千新来,赵清正,王争,陈艳,原志庆.E1A基因对人肺腺癌细胞化疗敏感性的影响[J].中国肿瘤生物治疗杂志,2000,7(2):124-126. 被引量:8
  • 5周彩存,徐瑛,倪健,周崧雯,徐建芳,吕梅君,王丽,陈杰,王智.H101溶瘤腺病毒联合长春瑞滨/顺铂一线治疗晚期非小细胞肺癌[J].肿瘤,2006,26(7):613-617. 被引量:12
  • 6Pfaffl MW.A new mathematical model for relative quantification in real-time RT-PCR[J].Nucleic Acids Res,2001,29(9):e45.
  • 7Peirson SN,Butler JN,Foster RG,et al.Experimental validation of novel and conventional approaches to quantitative real-time PCR data analysis[J].Nucleic Acids Res,2003,31(14):173-175.
  • 8Anklesaria P.Gene therapy:A molecular approach to cancer treatment[J].Curr Opin Mol Ther,2000,2(4):426-432.
  • 9Hendrie PC,Russell DW.Gene targeting with viral vectors[J].Mol Ther,2005,12(1):9-17.
  • 10Liu Y,Deisseroth A.Tumor vascular targeting therapy with viral vectors[J].Blood,2006,107(8):3027-3033.

二级参考文献39

共引文献44

同被引文献44

  • 1蔡秋凤,江瑞胜,欧阳高亮,鲍仕登.细胞周期检控点[J].细胞生物学杂志,2005,27(5):479-483. 被引量:4
  • 2李庆芳,吴祖泽.鞘氨醇激酶信号途径与血液肿瘤[J].中国实用内科杂志:临床前沿版,2006,26(3):401-403. 被引量:7
  • 3冯春来,王翎,董宁征.缺氧对肺腺癌细胞HIF-1α、GLUT-1、MMP-2表达影响的研究[J].肿瘤,2007,27(6):445-448. 被引量:1
  • 4STEWART S L, KING J B, THOMPSON T D, et al. Cancer mortality surveillance-united states, 1990-2000 [ J]. MMWR Surveill Summ, 2004, 53: 1-108.
  • 5DUMITRESCU R G, COTARLA I. Understanding breast cahcer risk-where do we stand in 2005 [ J ]. J Cell Mol Med, 2005, 9 : 208-221.
  • 6MACEYKA M, PAYNE S G, SPIEGEL S, et al. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis [ J ]. Biochim Biophys Acta, 2002, 1585: 193-201.
  • 7MURATA M, FUKUYAMA M, SATOH K, et al. Low shear stress can initiate yon Willebrand factor-dependent platelet aggregation in patients with type II B and platelet-type yon Willebrand disease [J]. J Clin Invest, 1993, 92 (3) : 1555-1558.
  • 8LIU H, SUGIURA M, NAVA V E, et al. Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform[J]. Biol Chem, 2000, 275 (26) : 19513- 19520.
  • 9DOLL F, PFE1LSCHIFTER J, HUWILER A. Prolactin upregulates sphingosine kinase-1 expression and activity in the human breast cancer cell line MCF7 and triggers enhanced proliferation and migration[J]. Endocr Relat Cancer, 2007, 14 (2): 325- 335.
  • 10HUWILER A, DOLL F, REN S, et al. Histamine increases sphingosine kinase-1 expression and activity in the human arterial endothelial cell line EA. hy 926 by a PKC-alpha-dependent mechanism[J]. Biochim Biophys Acta, 2006, 1761 (3) : 367-376.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部